Stay updated on Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial

Sign up to get notified when there's something new on the Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    A new revision entry, Revision v3.3.4, appears in the history. Revision v3.3.3 is removed from the list.
    Difference
    0.1%
    Check dated 2026-01-14T03:17:18.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    A new Revision: v3.3.3 has been added, and the HHS Vulnerability Disclosure link along with Revision: v3.3.2 has been removed.
    Difference
    0.1%
    Check dated 2025-12-23T21:06:43.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 on the page header. This is a system update and does not modify any study data, eligibility, or user actions.
    Difference
    0.1%
    Check dated 2025-11-25T10:57:12.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Removed the government funding status notice from the page; the trial record details and navigation remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-18T07:00:48.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The screenshots show a minor UI/layout adjustment to the Version History list on the Record History page, with formatting changes but the same version data and fields. No core content or statuses were altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T21:05:31.000Z thumbnail image
  8. Check
    109 days ago
    Change Detected
    Summary
    Major update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.
    Difference
    10%
    Check dated 2025-10-06T05:30:28.000Z thumbnail image

Stay in the know with updates to Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial page.